KDM1A and hepatocellular carcinoma: As BCL2 and cellular apoptosis played a central role in HCC cell response to sorafenib (37), we next explored potential role of KDM1A–FKBP8–BCL2 axis in sorafenib response and resistance, which was clinically relevant.